ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
Status:
Terminated
Trial end date:
2018-10-30
Target enrollment:
Participant gender:
Summary
This study is intended to explore and evaluate the pharmacodynamics and clinical efficacy of
the ionic contra-viral therapy CLS003 in immunocompromised and immunocompetent patients with
benign and premalignant HPV-induced genital lesions